Ximino

Product NDC: 10631-331
11-digit product format: 106310331
Labeler code: 10631
Product ID: 10631-331_c87b3360-adb8-444e-9591-52d2b97b8e08
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: minocycline hydrochloride
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Labeler: Sun Pharmaceutical Industries, Inc
Application: NDA201922
Marketing category: NDA
Marketing start: 2017-10-25
Marketing end: 0000-00-00
Substance: MINOCYCLINE HYDROCHLORIDE
Active strength: 90 mg/1
Pharmacologic classes: Tetracycline-class Drug [EPC],Tetracyclines [CS]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	10631-331		D	Discontinued by firm	2026-08-11
excluded package	package	10631-331	10631-331-05	D	Discontinued by firm	2026-08-11
excluded package	package	10631-331	10631-331-30	D	Discontinued by firm	2026-08-11
excluded package	package	10631-331	10631-331-69	D	Discontinued by firm	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 72 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10631-331-30	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10631-331-69	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10631-331-05	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10631-331-30	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10631-331-69	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10631-331-05	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10631-331-30	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10631-331-69	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10631-331-05	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10631-331-30	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10631-331-69	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10631-331-05	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10631-331-30	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10631-331-69	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10631-331-05	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10631-331-30	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10631-331-69	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10631-331-05	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10631-331-30	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10631-331-69	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10631-331-05	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10631-331-30	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10631-331-69	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10631-331-05	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10631-331-30	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10631-331-69	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10631-331-05	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	10631-331-30	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	10631-331-69	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	10631-331-05	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	10631-331-30	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	10631-331-69	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	10631-331-05	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	10631-331-30	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	10631-331-69	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	10631-331-05	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	10631-331-05	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	10631-331-69	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	10631-331-30	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	10631-331-05	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	10631-331-69	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	10631-331-30	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	10631-331-05	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	10631-331-69	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	10631-331-30	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
N201922-001	XIMINO	MINOCYCLINE HYDROCHLORIDE	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11
N201922-002	XIMINO	MINOCYCLINE HYDROCHLORIDE	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11
N201922-003	XIMINO	MINOCYCLINE HYDROCHLORIDE	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11
N201922-004	XIMINO	MINOCYCLINE HYDROCHLORIDE	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11
N201922-005	XIMINO	MINOCYCLINE HYDROCHLORIDE	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11

Orange Book patents#

Current patent rows page 1 of 1 · 9 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N201922-001	7919483	2027-03-07	U-124		2013-04-17
N201922-001	7541347	2027-04-02	U-917		2013-04-17
N201922-001	7544373	2027-04-02		Drug product	2013-04-17
N201922-003	7919483	2027-03-07	U-124
N201922-003	7541347	2027-04-02	U-917
N201922-003	7544373	2027-04-02		Drug product
N201922-005	7919483	2027-03-07	U-124
N201922-005	7541347	2027-04-02	U-917
N201922-005	7544373	2027-04-02		Drug product

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 6 · 205 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`5bbf6a4d5a75…`

Observed Orange Book patent history#

Patent history page 1 of 18 · 720 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N201922-001	7919483	2027-03-07	U-124		2013-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-001	7541347	2027-04-02	U-917		2013-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-001	7544373	2027-04-02		Drug product	2013-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-003	7919483	2027-03-07	U-124			`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-003	7541347	2027-04-02	U-917			`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-003	7544373	2027-04-02		Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-005	7919483	2027-03-07	U-124			`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-005	7541347	2027-04-02	U-917			`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-005	7544373	2027-04-02		Drug product		`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	7790705	2025-06-24	U-124		2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	8252776	2025-06-24	U-124		2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	8268804	2025-06-24	U-124		2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	7919483	2027-03-07	U-124		2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	7541347	2027-04-02	U-917		2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	7544373	2027-04-02		Drug product	2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	7790705	2025-06-24	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	8252776	2025-06-24	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	8268804	2025-06-24	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	7919483	2027-03-07	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	7541347	2027-04-02	U-917			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	7544373	2027-04-02		Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-005	7790705	2025-06-24	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-005	8252776	2025-06-24	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-005	8268804	2025-06-24	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-005	7919483	2027-03-07	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-005	7541347	2027-04-02	U-917			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-005	7544373	2027-04-02		Drug product		`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N201922-001	7790705	2025-06-24	U-124		2013-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-001	8252776	2025-06-24	U-124		2013-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-001	8268804	2025-06-24	U-124		2013-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-001	7919483	2027-03-07	U-124		2013-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-001	7541347	2027-04-02	U-917		2013-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-001	7544373	2027-04-02		Drug product	2013-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-003	7790705	2025-06-24	U-124			`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-003	8252776	2025-06-24	U-124			`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-003	8268804	2025-06-24	U-124			`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-003	7919483	2027-03-07	U-124			`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-003	7541347	2027-04-02	U-917			`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-003	7544373	2027-04-02		Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-005	7790705	2025-06-24	U-124			`6a471c1ec25d…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
10631-331-05	2023-07-03	These highlights do not include all the information needed to use XIMINO safely and effectively. See full prescribing information for XIMINO. XIMINO™ (minocycline hydrochloride) extended-release capsules, for oral use Initial U.S. Approval: 1971
10631-331-30	2023-07-03	These highlights do not include all the information needed to use XIMINO safely and effectively. See full prescribing information for XIMINO. XIMINO™ (minocycline hydrochloride) extended-release capsules, for oral use Initial U.S. Approval: 1971
10631-331-69	2023-07-03	These highlights do not include all the information needed to use XIMINO safely and effectively. See full prescribing information for XIMINO. XIMINO™ (minocycline hydrochloride) extended-release capsules, for oral use Initial U.S. Approval: 1971
10631-331-05	2020-01-31	These highlights do not include all the information needed to use XIMINO safely and effectively. See full prescribing information for XIMINO. XIMINO™ (minocycline hydrochloride) extended-release capsules, for oral use Initial U.S. Approval: 1971
10631-331-30	2020-01-31	These highlights do not include all the information needed to use XIMINO safely and effectively. See full prescribing information for XIMINO. XIMINO™ (minocycline hydrochloride) extended-release capsules, for oral use Initial U.S. Approval: 1971
10631-331-69	2020-01-31	These highlights do not include all the information needed to use XIMINO safely and effectively. See full prescribing information for XIMINO. XIMINO™ (minocycline hydrochloride) extended-release capsules, for oral use Initial U.S. Approval: 1971

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
10631-331-30	EA - Each	10631-331	e07fd938-3e4c-446a-9bef-447b08339268	1	2017-11-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
MINOCYCLINE HYDROCHLORIDE	ACTIVE INGREDIENT	0020414E5U	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
MINOCYCLINE	ACTIVE MOIETY	FYY3R43WGO	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
POLYETHYLENE GLYCOL 6000	INACTIVE INGREDIENT	30IQX730WE	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
SHELLAC	INACTIVE INGREDIENT	46N107B71O	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	XIMINO (MINOCYCLINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [RANBAXY LABORATORIES INC.]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0020414E5U	MINOCYCLINE HYDROCHLORIDE	13614-98-7	MINOCYCLINE HYDROCHLORIDE

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Ximino	Sun Pharmaceutical Industries, Inc \| CIPAN – Companhia Industrial Produtora	2018-11-17	HUMAN PRESCRIPTION DRUG LABEL	9